Ligand-steered modeling of the cannabinoid receptor 2: Successful applications to rationalize SAR data of selective CB2 inverse agonist and agonist compounds

被引：0
|
作者：
Phatak, Sharangdhar S.
Diaz, Philippe
Xu, Jijun
Astruc-Diaz, Fanny
Naguib, Mohammed
Cavasotto, Claudio N.
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Sch Hlth Informat Sci, Houston, TX USA
[2] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Pain Med, Houston, TX 77030 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 240卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
255-COMP
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cannabichromene is a cannabinoid CB2 receptor agonist
    Udoh, Michael
    Santiago, Marina
    Devenish, Steven
    McGregor, Iain S.
    Connor, Mark
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (23) : 4537 - 4547
  • [2] Involvement of cannabinoid CB2 receptor-mediated response and efficacy of cannabinoid CB2 receptor inverse agonist, JTE-907, in cutaneous inflammation in mice
    Ueda, Y
    Miyagawa, N
    Matsui, T
    Kaya, T
    Wamura, H
    Iwamura, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 520 (1-3) : 164 - 171
  • [3] Novel series of CB2 selective antagonists for the treatment of autoimmune disorders: Synthesis, functional evaluation and ligand-steered modeling
    Phatak, Sharangdhar S.
    Petrov, Ravil R.
    Astruc-Diaz, Fanny
    Cavasotto, Claudio N.
    Diaz, Philippe
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [4] Targeting the cannabinoid CB2 receptor:: Mutations, modeling and development of CB2 selective ligands
    Raitio, KH
    Salo, OMH
    Nevalainen, T
    Poso, A
    Järvinen, T
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (10) : 1217 - 1237
  • [5] HU-308:: A specific agonist for CB2, a peripheral cannabinoid receptor
    Hanus, L
    Breuer, A
    Tchilibon, S
    Shiloah, S
    Goldenberg, D
    Horowitz, M
    Pertwee, RG
    Ross, RA
    Mechoulam, R
    Fride, E
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (25) : 14228 - 14233
  • [6] Agonist selective regulation of g proteins by cannabinoid CB1 and CB2 receptors
    Glass, M
    Northup, JK
    MOLECULAR PHARMACOLOGY, 1999, 56 (06) : 1362 - 1369
  • [7] Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis
    El Bakali, Jamal
    Muccioli, Giulio G.
    Body-Malapel, Mathilde
    Djouina, Madjid
    Klupsch, Frederique
    Ghinet, Alina
    Barczyk, Amelie
    Renault, Nicolas
    Chavatte, Philippe
    Desreumaux, Pierre
    Lambert, Didier M.
    Millet, Regis
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (02): : 198 - 203
  • [8] Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates
    Gonsiorek, W.
    Lunn, C. A.
    Fan, X.
    Deno, G.
    Kozlowski, J.
    Hipkin, R. W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (08) : 1262 - 1271
  • [9] Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528 -: Implications for receptor biological responses
    Bouaboula, M
    Dussossoy, D
    Casellas, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) : 20397 - 20405
  • [10] Partial agonist-inverse agonist behaviour of 6′-azidohex-2′-yneΔ8-tetrahydrocannabinol at cannabinoid CB and CB2 receptors
    Gibson, TM
    Stevenson, LA
    Ross, RA
    Saha, B
    Razdan, RK
    Pertwee, RG
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128
12345